chronic urticaria

Search with Google Search with Bing
Information
Disease name
chronic urticaria
Disease ID
DOID:0080747
Description
"An urticaria that is characterized by the presence of urticaria for a period exceeding 6 weeks, assuming symptoms for most days of the week." [url:https\://pubmed.ncbi.nlm.nih.gov/30033911/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT06268470 Active, not recruiting Phase 2 Antiplatelet Therapy in Chronic Urticaria June 1, 2018 May 1, 2024
NCT00598611 Completed Phase 3 Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU) September 2007 August 2009
NCT00619801 Completed Phase 3 Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin March 2008 July 2008
NCT00628108 Completed Phase 3 Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months March 2008 September 2008
NCT00737451 Completed Association of Thyroid Autoimmunity and Chronic Urticaria March 2008 November 2010
NCT01803763 Completed Phase 2/Phase 3 Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients September 2012 March 2014
NCT01960283 Completed Phase 3 Methotrexate in the Treatment of Chronic Idiopathic Urticaria November 2011 May 2016
NCT02000648 Completed Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand January 2012 April 2015
NCT02213367 Completed Phase 3 Bilastine Updosing in Chronic Spontaneous Urticaria July 2014 March 2016
NCT02285023 Completed The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire November 2014 October 2015
NCT02285049 Completed Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test November 2014 January 2016
NCT02435238 Completed AWARE - Chronic Urticaria September 3, 2014 September 27, 2017
NCT02626221 Completed A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan) December 24, 2014 March 21, 2018
NCT03293225 Completed Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist August 24, 2017 May 24, 2019
NCT03436797 Completed Phase 2 A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria January 23, 2018 April 6, 2020
NCT04976192 Completed Phase 3 Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria August 30, 2021 April 5, 2024
NCT06063044 Completed Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children January 1, 2018 December 31, 2020
NCT01081574 Completed Phase 1/Phase 2 Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) January 2010 June 2012
NCT01111136 Completed N/A Stress Intervention for Chronic Urticaria March 2010 July 2010
NCT01250652 Completed Phase 4 Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses March 2011 March 2013
NCT01284426 Completed Natural History of Chronic Urticaria March 2003 March 2009
NCT01586091 Completed Phase 4 Safety Study of Levocetirizine and Fexofenadine February 2011 February 2012
NCT01610128 Completed Development of an Urticaria Control Test October 2011 August 2013
NCT01614834 Completed Validation of an Urticaria Control Test July 2012 September 2013
NCT01701583 Completed Phase 4 Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria April 2013 October 2017
NCT01713725 Completed Phase 2 Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria March 2012 June 2017
NCT01715740 Completed Phase 3 Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria November 2012 November 2015
NCT00481676 Completed Phase 2 Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria May 2007 April 2009
NCT05513079 Not yet recruiting N/A Positive Psychotherapy-Based Counseling (PPT) September 2022 December 2023
NCT03443362 Recruiting Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria. February 1, 2018 December 2022
NCT02358265 Terminated Phase 3 Chronic Urticaria - Long Term Assessment of Effects of Rupatadine December 2014 June 15, 2018
NCT01170949 Terminated Phase 2 Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria September 2008 April 2010
NCT02047136 Terminated N/A Dietary Treatment for Chronic Urticaria September 2013 July 2018
NCT04967092 Unknown status Phase 2 Modified Xiao-Feng Powder for Chronic Urticaria August 15, 2021 September 30, 2023
NCT04584190 Unknown status Real Life Use of Omalizumab in Chronic Urticaria July 1, 2020 December 30, 2020
NCT01425593 Unknown status T Cell Function in Chronic Idiopathic Urticaria March 2009 December 2012
NCT03163875 Unknown status Quality of Life in Patients With Chronic Urticaria June 1, 2017 August 1, 2018
NCT01047137 Withdrawn N/A Response of Urticaria to Stress Intervention July 2010 March 2011
NCT01073852 Withdrawn N/A Hydroxychloroquine Efficacy in Chronic Urticaria June 2011 June 2012
Disase is a (Disease Ontology)
DOID:1555
Cross Reference ID (Disease Ontology)
MESH:D000080223
MedGen concept unique identifier (MedGen Concept name)
C0263338
MedGen unique identifier (MedGen Concept name)
537829